Recruiting
A Multicenter RCT of "3+7" vs Venetoclax + CACAG in Newly Diagnosed Mid/High-Risk AML Patients
NCT06928376
- Conditions
- Acute Myeloid Leukemia, First Line Therapy, Hematologic Diseases, +6 more
- Locations
-
- Chinese PLA General Hospital Beijing, Beijing Municipality, China